Leiden Early Drug Discovery & Development (LED3)
@led3hub.bsky.social did:plc:jnlt3o3km3ebst2vcigkwdch
LED3 is a hub of scientists working on early drug discovery at the Leiden Institute of Chemistry, the Leiden Academic Centre for Drug Research, the Institute of Biology Leiden and the Leiden Institute of Advanced Computer Science. @[email protected]
Bluesky’a katılma tarihi:
- Takipçi
- 819
- Takip edilen
- 42
- Post
- 231
- Sıralamaya girdiği gün
- 0
Özet
Leiden Early Drug Discovery & Development (LED3) (@led3hub.bsky.social), 19 Eylül 2023 tarihinde katılan bir Bluesky kullanıcısı. 819 takipçisi var, 42 hesabı takip ediyor ve 231 post paylaştı.
Sıralama geçmişi
Bu hesabın postlarının Debya günlük listesine girdiği en iyi günler.
Bu hesap henüz günlük sıralamaya girmedi.
Son beğendiği postlar
Bluesky ağındaki herkese açık beğeniler.
I had an amazing time visiting @yale.edu and presenting some of the work of our group. A huge thank you to @jeanjuchung.bsky.social and Felix Zhu for inviting me and to everyone for the interesting discussions (@craigmcrews.bsky.social, Hongying Shen, Jing Hughes, Yansheng Liu, David Zenisek).
Postu gösterAnother great LED3 Lecture.
Postu gösterAmazing @led3hub.bsky.social Lecture by Marc Robillard from Tagworks Pharmaceuticals. He talked about the development of Click-to-Release chemistry and its application to antibody-drug conjugates that can be activated by a chemical trigger. www.nature.com/articles/s42...
Postu göster#DrugDiscovery #Click #ClickChemistry #ClickToRelease #ADC #ChemBio #ChemSky #Chemistry
Postu göster🔹 Structural Validation: In collaboration with Tessa Gote and @armstrongchembio.bsky.social within our @led3hub.bsky.social, we resolved a crystal structure of the protein in complex with our top hit. This revealed covalent engagement at C111 and key interactions for future optimization. (5/8)
Postu göster
Blokladığı hesaplar
Bluesky’da bloklar herkese açık kayıtlardır.
Bu hesap kimseyi bloklamıyor.